Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 2016;315(8):801–810. DOI: 10.1001/jama.2016.0287.
Manu Shankar-Hari M, Phillips GS, Levy ML, Seymour CW, Liu VX, Deutschman CS, et al. Developing a new definition and assessing new clinical criteria for septic shock: For the Third International Consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 2016;315(8):775–787. DOI: 10.1001/jama.2016.0289.
Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: International guidelines for management of sepsis and septic shock 2021. Intensive Care Med 2021;47(11):1181–1247. DOI: 10.1007/s00134-021-06506-y.
Badawi O, Waite MD, Fuhrman SA, Zuckerman IH. Association between intensive care unit-acquired dysglycemia and in-hospital mortality. Crit Care Med;40(12):3180–3188. DOI: 10.1097/CCM.0b013e3182656ae5.
Todi S, Bhattacharya M. Glycemic variability and outcome in critically ill. Indian J Crit Care Med 2014;18(5):285–290. DOI: 10.4103/0972-5229.132484.
Fong KM, Au SY, Ng GWY. Glycemic control in critically ill patients with or without diabetes. BMC Anesthesiol 2022;22(1):227. DOI: 10.1186/s12871-022-01769-4.
Gómez AM, Muñoz OM, Marin A, Fonseca MC, Rondon M, Robledo Gómez MA, et al. Different indexes of glycemic variability as identifiers of patients with risk of hypoglycemia in type 2 diabetes mellitus. J Diabetes Sci Technol 2018;12(5):1007–1015. DOI: 10.1177/1932296818758105.
Annane D, Renault A, Brun-Buisson C, Megarbane B, Quenot JP, Siami S, et al. Hydrocortisone plus Fludrocortisone for adults with septic shock. N Engl J Med 2018;378(9):809–818. DOI: 10.1056/NEJMoa1705716.
Venkatesh B, Finfer S, Cohen J, Rajbhandari D, Arabi Y, Bellomo R, et al. ADRENAL trial investigators and the Australian–New Zealand Intensive Care Society Clinical Trials Group. Adjunctive glucocorticoid therapy in patients with septic shock. N Engl J Med 2018;378(9):797–808. DOI: 10.1056/NEJMoa1705835.
Salhotra R, Sharahudeen A, Tyagi A, Rautela RS, Kemprai R. Effect of continuous infusion vs bolus dose of hydrocortisone in septic shock: A prospective randomized study. Indian J Crit Care Med 2024;28(9):837–841.
Loisa P, Parviainen I, Tenhunen J, Hovilehto S, Ruokonen E. Effect of mode of hydrocortisone administration on glycemic control in patients with septic shock: A prospective randomized trial. Crit Care 2007;11(1):R21. DOI: 10.1186/cc5696.
